{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:26:18Z","timestamp":1778811978928,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T00:00:00Z","timestamp":1457654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T00:00:00Z","timestamp":1457654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recently, cell-based therapeutic lymphangiogenesis has emerged and provided hope for lymphatic regeneration. Previous studies have demonstrated that secretomes of mesenchymal stem cells (MSCs) facilitate the regeneration of various damaged tissues. This study was conducted to evaluate the lymphangiogenic potential of hypoxic conditioned media (HCM) from MSCs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To investigate the effects of MSC-secreted factors in starved human lymphatic endothelial cells (hLEC), hLECs were treated with endothelial basal medium (EBM)-2 (control), normoxic conditioned media (NCM), or HCM <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo.<\/jats:italic><\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>MSCs expressed lymphangiogenic factors including EGF, FGF2, HGF, IGF-1, and VEGF-A and -C. hLECs were treated with each medium. hLEC proliferation, migration, and tube formation were improved under HCM compared with NCM. Moreover, expression of mitochondrial-related factors, MFN1and 2, were improved in HCM-treated hLECs. Lymphedema mice injected with HCM showed markedly decreased lymphedema via increased lymphatic vessel formation when compared with EBM-2- or NCM-treated mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study suggested that HCM from MSCs contain high levels of secreted lymphangiogenic factors and promote lymphangiogenesis by regulating mitochondrial-related factors. Thus, treatment with HCM may be a therapeutic strategy for lymphedema.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-016-0296-1","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T12:53:25Z","timestamp":1457700805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hypoxic conditioned medium from mesenchymal stem cells promotes lymphangiogenesis by regulation of mitochondrial-related proteins"],"prefix":"10.1186","volume":"7","author":[{"given":"Chang Youn","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Young","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soyeon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onju","family":"Ham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woochul","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Hyun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,11]]},"reference":[{"key":"296_CR1","volume-title":"AHRQ technology assessments. Diagnosis and treatment of secondary lymphedema","author":"M Oremus","year":"2010","unstructured":"Oremus M, Walker K, Dayes I, Raina P. AHRQ technology assessments. Diagnosis and treatment of secondary lymphedema. Rockville: Agency for Healthcare Research and Quality (US); 2010."},{"issue":"2","key":"296_CR2","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jaad.2008.04.013","volume":"59","author":"K Kerchner","year":"2008","unstructured":"Kerchner K, Fleischer A, Yosipovitch G. Lower extremity lymphedema update: pathophysiology, diagnosis, and treatment guidelines. J Am Acad Dermatol. 2008;59(2):324\u201331. doi:10.1016\/j.jaad.2008.04.013.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"296_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000343699","volume":"50","author":"IG Kim","year":"2013","unstructured":"Kim IG, Lee JY, Lee DS, Kwon JY, Hwang JH. Extracorporeal shock wave therapy combined with vascular endothelial growth factor-C hydrogel for lymphangiogenesis. J Vasc Res. 2013;50(2):124\u201333. doi:10.1159\/000343699.","journal-title":"J Vasc Res"},{"issue":"3","key":"296_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/scd.2014.0390","volume":"24","author":"S Qi","year":"2015","unstructured":"Qi S, Pan J. Cell-based therapy for therapeutic lymphangiogenesis. Stem Cells Dev. 2015;24(3):271\u201383. doi:10.1089\/scd.2014.0390.","journal-title":"Stem Cells Dev"},{"issue":"3","key":"296_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jdermsci.2013.04.024","volume":"71","author":"D Marino","year":"2013","unstructured":"Marino D, Angehrn Y, Klein S, Riccardi S, Baenziger-Tobler N, Otto VI, et al. Activation of the epidermal growth factor receptor promotes lymphangiogenesis in the skin. J Dermatol Sci. 2013;71(3):184\u201394. doi:10.1016\/j.jdermsci.2013.04.024.","journal-title":"J Dermatol Sci"},{"issue":"9","key":"296_CR6","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1182\/blood-2005-06-2538","volume":"107","author":"R Cao","year":"2006","unstructured":"Cao R, Bjorndahl MA, Gallego MI, Chen S, Religa P, Hansen AJ, et al. Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood. 2006;107(9):3531\u20136. doi:10.1182\/blood-2005-06-2538.","journal-title":"Blood"},{"issue":"32","key":"296_CR7","doi-asserted-by":"publisher","first-page":"11658","DOI":"10.1073\/pnas.0404272101","volume":"101","author":"LK Chang","year":"2004","unstructured":"Chang LK, Garcia-Cardena G, Farnebo F, Fannon M, Chen EJ, Butterfield C, et al. Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci U S A. 2004;101(32):11658\u201363. doi:10.1073\/pnas.0404272101.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"296_CR8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1172\/JCI15830","volume":"111","author":"YS Yoon","year":"2003","unstructured":"Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C, et al. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest. 2003;111(5):717\u201325. doi:10.1172\/jci15830.","journal-title":"J Clin Invest"},{"issue":"1","key":"296_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ni1013","volume":"5","author":"MJ Karkkainen","year":"2004","unstructured":"Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 2004;5(1):74\u201380. doi:10.1038\/ni1013.","journal-title":"Nat Immunol"},{"issue":"7","key":"296_CR10","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1172\/JCI20465","volume":"113","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004;113(7):1040\u201350. doi:10.1172\/jci20465.","journal-title":"J Clin Invest"},{"issue":"19","key":"296_CR11","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1016\/j.biomaterials.2011.02.051","volume":"32","author":"JH Hwang","year":"2011","unstructured":"Hwang JH, Kim IG, Lee JY, Piao S, Lee DS, Lee TS, et al. Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel. Biomaterials. 2011;32(19):4415\u201323. doi:10.1016\/j.biomaterials.2011.02.051.","journal-title":"Biomaterials"},{"key":"296_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1476-9255-2-8","volume":"2","author":"JM Ryan","year":"2005","unstructured":"Ryan JM, Barry FP, Murphy JM, Mahon BP. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond). 2005;2:8. doi:10.1186\/1476-9255-2-8.","journal-title":"J Inflamm (Lond)"},{"issue":"5","key":"296_CR13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1006\/jmcc.2001.1367","volume":"33","author":"M Zhang","year":"2001","unstructured":"Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol. 2001;33(5):907\u201321. doi:10.1006\/jmcc.2001.1367.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"296_CR14","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nm1040","volume":"10","author":"JM Nygren","year":"2004","unstructured":"Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med. 2004;10(5):494\u2013501. doi:10.1038\/nm1040.","journal-title":"Nat Med"},{"issue":"21\u201322","key":"296_CR15","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1089\/ten.tea.2012.0646","volume":"19","author":"KJ Portalska","year":"2013","unstructured":"Portalska KJ, Groen N, Krenning G, Georgi N, Mentink A, Harmsen MC, et al. The effect of donor variation and senescence on endothelial differentiation of human mesenchymal stromal cells. Tissue Eng Part A. 2013;19(21\u201322):2318\u201329. doi:10.1089\/ten.TEA.2012.0646.","journal-title":"Tissue Eng Part A"},{"key":"296_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13287-015-0165-3","volume":"6","author":"X Lin","year":"2015","unstructured":"Lin X, Robinson M, Petrie T, Spandler V, Boyd WD, Sondergaard CS. Small intestinal submucosa-derived extracellular matrix bioscaffold significantly enhances angiogenic factor secretion from human mesenchymal stromal cells. Stem Cell Res Ther. 2015;6:164. doi:10.1186\/s13287-015-0165-3.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"296_CR17","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2217\/rme.10.72","volume":"5","author":"N Joyce","year":"2010","unstructured":"Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta JA. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med. 2010;5(6):933\u201346. doi:10.2217\/Rme.10.72.","journal-title":"Regen Med"},{"key":"296_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12967-014-0260-8","volume":"12","author":"M Madrigal","year":"2014","unstructured":"Madrigal M, Rao KS, Riordan NH. A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J Transl Med. 2014;12:260. doi:10.1186\/s12967-014-0260-8.","journal-title":"J Transl Med"},{"issue":"1","key":"296_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2217\/rme.09.74","volume":"5","author":"PR Baraniak","year":"2010","unstructured":"Baraniak PR, McDevitt TC. Stem cell paracrine actions and tissue regeneration. Regen Med. 2010;5(1):121\u201343. doi:10.2217\/Rme.09.74.","journal-title":"Regen Med"},{"issue":"9","key":"296_CR20","doi-asserted-by":"publisher","first-page":"e106976","DOI":"10.1371\/journal.pone.0106976","volume":"9","author":"L Maertens","year":"2014","unstructured":"Maertens L, Erpicum C, Detry B, Blacher S, Lenoir B, Carnet O, et al. Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis. Plos One. 2014;9(9):e106976. doi:10.1371\/journal.pone.0106976.","journal-title":"Plos One"},{"issue":"2","key":"296_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/CIRCULATIONAHA.108.793208","volume":"119","author":"C Conrad","year":"2009","unstructured":"Conrad C, Niess H, Huss R, Huber S, von Luettichau I, Nelson PJ, et al. Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo. Circulation. 2009;119(2):281\u20139. doi:10.1161\/CIRCULATIONAHA.108.793208.","journal-title":"Circulation"},{"issue":"7","key":"296_CR22","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/stem.1375","volume":"31","author":"M Gil-Ortega","year":"2013","unstructured":"Gil-Ortega M, Garidou L, Barreau C, Maumus M, Breasson L, Tavernier G, et al. Native adipose stromal cells egress from adipose tissue in vivo: evidence during lymph node activation. Stem Cells. 2013;31(7):1309\u201320. doi:10.1002\/stem.1375.","journal-title":"Stem Cells"},{"issue":"4","key":"296_CR23","doi-asserted-by":"publisher","first-page":"e96161","DOI":"10.1371\/journal.pone.0096161","volume":"9","author":"L Chen","year":"2014","unstructured":"Chen L, Xu Y, Zhao J, Zhang Z, Yang R, Xie J, et al. Conditioned medium from hypoxic bone marrow-derived mesenchymal stem cells enhances wound healing in mice. PLoS One. 2014;9(4):e96161. doi:10.1371\/journal.pone.0096161.","journal-title":"PLoS One"},{"issue":"4","key":"296_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/scd.2012.0273","volume":"22","author":"A Burlacu","year":"2013","unstructured":"Burlacu A, Grigorescu G, Rosca AM, Preda MB, Simionescu M. Factors secreted by mesenchymal stem cells and endothelial progenitor cells have complementary effects on angiogenesis in vitro. Stem Cells Dev. 2013;22(4):643\u201353. doi:10.1089\/scd.2012.0273.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"296_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/35036035","volume":"1","author":"MJ Berridge","year":"2000","unstructured":"Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000;1(1):11\u201321. doi:10.1038\/35036035.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5381","key":"296_CR26","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","volume":"281","author":"DR Green","year":"1998","unstructured":"Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281(5381):1309\u201312. doi:10.1126\/science.281.5381.1309.","journal-title":"Science"},{"issue":"2","key":"296_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","volume":"552","author":"JF Turrens","year":"2003","unstructured":"Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol Lond. 2003;552(2):335\u201344. doi:10.1113\/jphysiol.2003.049478.","journal-title":"J Physiol Lond"},{"issue":"15","key":"296_CR28","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1091\/mbc.E09-03-0252","volume":"20","author":"ZY Song","year":"2009","unstructured":"Song ZY, Ghochani M, McCaffery JM, Frey TG, Chan DC. Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol Biol Cell. 2009;20(15):3525\u201332. doi:10.1091\/mbc.E09-03-0252.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"296_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1083\/jcb.200802164","volume":"182","author":"XJ Han","year":"2008","unstructured":"Han XJ, Lu YF, Li SA, Kaitsuka T, Sato Y, Tomizawa K, et al. CaM kinase I alpha-induced phosphorylation of Drp1 regulates mitochondrial morphology. J Cell Biol. 2008;182(3):573\u201385. doi:10.1083\/jcb.200802164.","journal-title":"J Cell Biol"},{"key":"296_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.vph.2015.05.007","volume":"72","author":"Q Zhou","year":"2015","unstructured":"Zhou Q, Gensch C, Keller C, Schmitt H, Esser J, Moser M, et al. MnTBAP stimulates angiogenic functions in endothelial cells through mitofusin-1. Vasc Pharmacol. 2015;72:163\u201371. doi:10.1016\/j.vph.2015.05.007.","journal-title":"Vasc Pharmacol"},{"issue":"6","key":"296_CR31","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.yjmcc.2011.07.023","volume":"51","author":"JJ Lugus","year":"2011","unstructured":"Lugus JJ, Ngoh GA, Bachschmid MM, Walsh K. Mitofusins are required for angiogenic function and modulate different signaling pathways in cultured endothelial cells. J Mol Cell Cardiol. 2011;51(6):885\u201393. doi:10.1016\/j.yjmcc.2011.07.023.","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"296_CR32","doi-asserted-by":"publisher","first-page":"e000877","DOI":"10.1161\/JAHA.112.000877","volume":"1","author":"Y Shimizu","year":"2012","unstructured":"Shimizu Y, Shibata R, Shintani S, Ishii M, Murohara T. Therapeutic lymphangiogenesis with implantation of adipose-derived regenerative cells. J Am Heart Assoc. 2012;1(4):e000877. doi:10.1161\/jaha.112.000877.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"296_CR33","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1161\/01.CIR.0000121425.42966.F1","volume":"109","author":"J Rehman","year":"2004","unstructured":"Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109(10):1292\u20138. doi:10.1161\/01.CIR.0000121425.42966.F1.","journal-title":"Circulation"},{"issue":"3","key":"296_CR34","doi-asserted-by":"publisher","first-page":"C675","DOI":"10.1152\/ajpcell.00437.2007","volume":"294","author":"PR Crisostomo","year":"2008","unstructured":"Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, Meldrum DR. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol. 2008;294(3):C675\u201382. doi:10.1152\/ajpcell.00437.2007.","journal-title":"Am J Physiol Cell Physiol"},{"key":"296_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1479-5876-9-10","volume":"9","author":"A Efimenko","year":"2011","unstructured":"Efimenko A, Starostina E, Kalinina N, Stolzing A. Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning. J Transl Med. 2011;9:10. doi:10.1186\/1479-5876-9-10.","journal-title":"J Transl Med"},{"issue":"43","key":"296_CR36","doi-asserted-by":"publisher","first-page":"15593","DOI":"10.1073\/pnas.0507865102","volume":"102","author":"M Bjorndahl","year":"2005","unstructured":"Bjorndahl M, Cao R, Nissen LJ, Clasper S, Johnson LA, Xue Y, et al. Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. Proc Natl Acad Sci U S A. 2005;102(43):15593\u20138. doi:10.1073\/pnas.0507865102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"296_CR37","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3892\/Ol.2015.2868","volume":"9","author":"J Zhan","year":"2015","unstructured":"Zhan J, Li YH, Yu J, Zhao YY, Cao WM, Ma J, Sun XX, Sun L, Qian H, Zhu W, Xu WR. Culture medium of bone marrow-derived human mesenchymal stem cells effects lymphatic endothelial cells and tumor lymph vessel formation. Oncol Lett. 2015;9:1221\u20131226. doi: 10.3892\/Ol.2015.2868","journal-title":"Oncol Lett."},{"issue":"13","key":"296_CR38","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1182\/blood-2005-01-0226","volume":"106","author":"P Religa","year":"2005","unstructured":"Religa P, Cao RH, Bjorndahl M, Zhou ZJ, Zhu ZP, Cao YH. Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood. 2005;106(13):4184\u201390. doi: 10.1182\/blood-2005-01-0226.","journal-title":"Blood"},{"issue":"12","key":"296_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028947","volume":"6","author":"MT Dellinger","year":"2011","unstructured":"Dellinger MT, Brekken RA. Phosphorylation of Akt and ERK1\/2 Is Required for VEGF-A\/VEGFR2-Induced Proliferation and Migration of Lymphatic Endothelium. Plos One. 2011;6(12):e28947. doi: 10.1371\/journal.pone.0028947.","journal-title":"Plos One"},{"issue":"6","key":"296_CR40","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.yjmcc.2011.09.004","volume":"51","author":"MN Sack","year":"2011","unstructured":"Sack MN. Mitofusin function is dependent on the distinct tissue and organ specific roles of mitochondria. Mol Cell Cardiol. 2011;51(6):881\u20132. doi: 10.1016\/j.yjmcc.2011.09.004.","journal-title":"Mol Cell Cardiol"},{"key":"296_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1752-0509-5-115","volume":"5","author":"P Yde","year":"2011","unstructured":"Yde P, Mengel B, Jensen MH, Krishna S, Trusina A. Modeling the NF-kappaB mediated inflammatory response predicts cytokine waves in tissue. BMC Syst Biol. 2011;5:115. doi: 10.1186\/1752-0509-5-115.","journal-title":"BMC Syst Biol"},{"issue":"6","key":"296_CR42","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1210\/jc.2006-2865","volume":"92","author":"A Khosravi","year":"2007","unstructured":"Khosravi A, Cutler CM, Kelly MH, Chang R, Royal RE, Sherry RM, et al. Determination of the elimination half-life of fibroblast growth factor-23. J Clin Endocrinol Metab. 2007;92(6):2374\u20137. doi:10.1210\/jc.2006-2865.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0296-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-016-0296-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0296-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0296-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T06:07:02Z","timestamp":1637042822000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-016-0296-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["296"],"URL":"https:\/\/doi.org\/10.1186\/s13287-016-0296-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,11]]},"assertion":[{"value":"17 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"38"}}